News & Insights

News
03.04.2020

EMA and FDA have activated plans to fast track the development and approval of therapeutics against COVID-19.

Read more
EMA extends nitrosamine risk assessments to investigational drugs featured image

Insights
02.04.2020

EMA extends nitrosamine risk assessments to investigational drugs

Read more
Ardena Assen is doubling its capacity – Update 25.03.2020 featured image

News
25.03.2020

Ardena Assen is doubling its capacity – Update 25.03.2020

Read more
GHO Capital acquires Ardena featured image

News
09.01.2020

GHO Capital acquires Ardena

Read more
EMA request for Nitrosamine Risk Assessment featured image

Insights
17.10.2019

EMA request for Nitrosamine Risk Assessment

Read more

News
16.10.2019

Ardena Assen is doubling its capacity

Read more
BVA award nominee featured image

News
13.09.2019

BVA award nominee

Read more
Ardena launches Life Science Ingredients Arm featured image

News
31.07.2019

Ardena launches Life Science Ingredients Arm

Read more
Ardena launches bimonthly newsletter featured image

News
07.02.2019

Ardena launches bimonthly newsletter

Read more
Ardena cements growth and expansion with new HQ featured image

News
08.11.2018

Ardena cements growth and expansion with new HQ

Read more